Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Nature Reviews. Disease Primers|May 19, 2016
Non-small-cell lung cancerCesare Gridelli, Antonio Rossi, David P Carbone, et al.
Cancer|July 28, 2011
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lungGilberto de Lima Lopes, Joel E Segel, Daniel S W Tan, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|May 15, 2020
Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathyAlex Molassiotis, Bryony Dawkins, Roberta Longo, et al.
Clinical Lung Cancer|October 16, 2012
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung CancerDavid R Spigel, Martin J Edelman, Tony Mok, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2014
Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancerCeline Pallaud, Martin Reck, Erzsebet Juhasz, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2014
Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysisSanjay Popat, Tony Mok, James Chih-Hsin Yang, et al.
BMC Cancer|October 11, 2011
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerYi-Long Wu, Keunchil Park, Ross A Soo, et al.
BMC Neurology|December 16, 2014
Subcortical white matter infarcts predict 1-year outcome of fatigue in strokeWai Kwong Tang, Yang Kun Chen, Hua Jun Liang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 30, 2024
A pragmatic guide for management of adverse events associated with lorlatinibGeoffrey Liu, Julien Mazieres, Jan Stratmann, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2026
Acute toxicity and quality of life with stereotactic body radiotherapy versus conventional fractionated intensity-modulated radiotherapy to the prostate and pelvis in high-risk prostate cancer (SRAM): A randomized phase II trialDarren Mc Poon, Kenneth Wong, Daisy Lam, et al.
Pageof 16